Journal
FEBS LETTERS
Volume 582, Issue 1, Pages 117-131Publisher
WILEY
DOI: 10.1016/j.febslet.2007.11.051
Keywords
obesity; type 2 diabetes; metabolic syndrome; insulin resistance; dyslipidemia; TNF signalling; lipid metabolism; antiadipogenesis
Funding
- Biotechnology and Biological Sciences Research Council [JF16994] Funding Source: researchfish
- Biotechnology and Biological Sciences Research Council [JF16994] Funding Source: Medline
Ask authors/readers for more resources
Dyslipidemia and insulin resistance are commonly associated with catabolic or lipodystrophic conditions (such as cancer and sepsis) and with pathological states of nutritional overload (such as obesity-related type 2 diabetes). Two common features of these metabolic disorders are adipose tissue dysfunction and elevated levels of tumour necrosis factor-alpha (TNF-alpha). Herein, we review the multiple actions of this pro-inflammatory adipokine on adipose tissue biology. These include inhibition of carbohydrate metabolism, lipogenesis, adipogenesis and thermogenesis and stimulation of lipolysis. TNF-alpha can also impact the endocrine functions of adipose tissue. Taken together, TNF-alpha contributes to metabolic dysregulation by impairing both adipose tissue function and its ability to store excess fuel. The molecular mechanisms that underlie these actions are discussed. (C) 2007 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available